Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Jan-Feb;256-257(1-2):83-93.
doi: 10.1023/b:mcbi.0000009860.86969.72.

Functional aspects of cellular microcompartmentation in the development of neurodegeneration: mutation induced aberrant protein-protein associations

Affiliations
Review

Functional aspects of cellular microcompartmentation in the development of neurodegeneration: mutation induced aberrant protein-protein associations

Judit Ovádi et al. Mol Cell Biochem. 2004 Jan-Feb.

Abstract

Research in the last 10 years has revealed that the development of neurodegeneration is a multistep process during which one or few specific mutant protein species of altered conformation initiate aberrant protein-protein interactions resulting in aggregates forming plaques. This review focuses on the heteroassociations of the mutant proteins with subcellular structures, such as cytoskeleton, cell membranes or with glycolytic enzymes, which may be crucial in the initiation of neurodegeneration such as in Huntington's disease or Alzheimer's disease. Triosephosphate isomerase enzymopathy is a unique glycolytic enzyme deficiency coupled with neurodegeneration. We present data on the mutation induced misfolding process, which likely plays a crucial role in the enhanced associations of the enzyme with the truncated fragment of the isomerase, with the red cell membrane or with the microtubular network. On the basis of our recent clinical and experimental results obtained with two compound heterozygote Hungarian brothers it became obvious that the mutations alone are not sufficient to explain the development of the neurological sympthomes. This underscores the fact that the mutations alone are not enough for the development of the clinical phenotype of a disease.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neuron. 1997 Dec;19(6):1151-4 - PubMed
    1. Biochem Biophys Res Commun. 1999 Oct 22;264(2):605-10 - PubMed
    1. Hum Mol Genet. 2000 May 22;9(9):1259-71 - PubMed
    1. Neuron. 1995 May;14 (5):1065-74 - PubMed
    1. Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2719-23 - PubMed

Publication types